About Erykine 40000 Iu Injection
Erykine 40000 IU Injection - presented in a pre-filled syringe - is a preeminent, affordable solution intended for the treatment of anemia related to cancer chemotherapy. Marketed by Medicine Planet and designed with personalisation in mind, it features the latest sterile technologies, ensuring an impeccable and ready-to-use product. With its potent composition of Recombinant Human Erythropoietin Alfa, Erykine guarantees terrific reliability in stimulating erythropoiesis. The clear, colorless formulation supports a seamless administration, making it a standout therapeutic option for healthcare professionals seeking quality and safety.
Versatile Application & Distinct Features
Erykine 40000 IU Injection serves as a hematopoietic agent specifically crafted for cancer-related anemia, particularly during chemotherapy. Its material feature includes a sterile, pre-filled syringe, guaranteeing accurate and safe dosing. Its plant application highlights advanced biotechnological fermentation for impeccable purity, ensuring efficacy and patient safety. This solution is clear and colorless, devoid of odor, with excellent enzymatic activity to support red blood cell production through optimal erythropoiesis.
Premium Packaging & Global Export
The Erykine 40000 IU Injection comes in stock-ready, pre-filled syringes meant for single-use, ensuring minimal contamination and maximum efficiency. Secure packaging ensures medicine is protected during drop-off and shipping. As a trusted exporter, manufacturer, and supplier from India, Medicine Planet delivers promptly to main export markets worldwide. Samples can be provided, generally with a nominal charge, supporting healthcare facilities aiming for quick access to this terrific, prescription-only therapeutic solution.
FAQ's of Erykine 40000 Iu Injection:
Q: How should Erykine 40000 IU Injection be stored?
A: Store Erykine 40000 IU Injection at temperatures between 2-8C and avoid freezing. Always check the shelf life mentioned on the packaging.
Q: What is the main benefit of using Erykine 40000 IU Injection?
A: Erykine is designed to manage anemia resulting from cancer chemotherapy by stimulating erythropoiesis, thus helping to restore healthy red blood cell levels.
Q: When is Erykine 40000 IU Injection typically prescribed?
A: This injection is prescribed when patients undergoing cancer chemotherapy develop anemia and require an effective hematopoietic agent to alleviate symptoms.
Q: Where can I administer Erykine 40000 IU Injection?
A: Administration should be carried out in a clinical setting by a qualified healthcare professional, either subcutaneously or intravenously, as directed.
Q: What features make Erykine 40000 IU Injection ready for immediate use?
A: Erykine comes as a sterile, clear, colorless, pre-filled syringe with the needle included, providing convenience and minimizing preparation steps before administration.